fbpx

Brief

K4D Helpdesk Report 785.3

COVID-19 Health Evidence Summary No.3

Published on 23 March 2020

This weekly COVID-19 Health Evidence Summary is to signpost DFID and other UK government departments to the latest relevant evidence and discourse on COVID-19 to inform and support their response.

This summary covers thirteen publications including the global megatrial of the four most promising coronavirus treatments by WHO, genome sequence alliance to map spread of coronavirus by the UK, Viral dynamics in mild and severe cases of COVID-19, COVID-19 vaccine development, A trial of lopinavir-ritonavir in adults hospitalised with severe COVID-19, Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic, Conserving Supply of Personal Protective Equipment, Rational use of face masks in the COVID-19 pandemic, Scientific evidence published that the Scientific Advisory Group for Emergencies (SAGE) used to advise the UK Government’s response, SARS-CoV-2 viral load in upper respiratory specimens of infected patients, The coronavirus pandemic in five powerful charts, Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand, and Publishers make coronavirus (COVID-19) content freely available and reusable. The summary also covers report on tracking COVID-19 cases, modelling and forecasting, online course and COVID-19 resource hubs that are accessible by public.

Cite this publication

Millington, K.A. (2020), COVID-19 Health Evidence Summary 3, K4D Evidence Summary, Brighton: IDS

Citation copied

Access this publication

Read full publication online in OpenDocs

Partners

Supported by
UKaid

Publication details

authors
Kerry Millington
language
English

Share

About this publication

Related content